The Indiana University School of Medicine (IUSM), the Stark Neurosciences Research Institute and the Indiana University Precision Health Initiative (PHI) seeks to recruit faculty with a research program focused in Alzheimer’s disease and related dementias/neurodegeneration. PHI was created with the bold goal of addressing major and large-scale health problems facing humanity through multidisciplinary teams of outstanding, innovative researchers. Precision Health was selected as the first recipient of funding from Indiana University Grand Challenges Program that is a $300 million research expansion across the entire University. The $120 million investment in Precision Health will be leveraged to recruit approximately 40 new, full-time faculty members on the Indiana University campuses in Bloomington and Indianapolis. Precision Health has supported the creation of new facilities, centers, and user platforms, including new gene editing and sequencing cores at the IUSM, and a Good Manufacturing Practice Cell Therapy (GMP) facility to produce cellular therapeutics. This investment will be leveraged with other IUSM resources to significant expand the scope of this initiative. Genomic Medicine is one of the specific areas that will be supported with substantial resources to build programs. This is an opportunity to create a vision for research and clinical implementation of genomic medicine across one of the largest health systems in the nation.
Research in the area of neurodegeneration has rapidly become a major focus at the IUSM with National Institutes of Health -supported Alzheimer's research funding increasing from $7.6M in 2015 to $23.1M in 2017 (and likely further substantial increases in 2018). This includes many national programs, projects and consortia including the Indiana Alzheimer Disease Center which supports clinical and basic science research; the Indiana University/Jackson Laboratory Model Organism Development and Evaluation for Late-Onset AD (MODEL-AD) consortium which develops, validates and disseminates new, precise animal models of Alzheimer’s disease (AD) and performs state-of-the-art pre-clinical testing of novel AD therapeutics; National Institute on Aging (NIA), The National Institute of Neurological Disorders and Stroke (NINDS) and Michael J. Fox Foundation-supported centralized biorepositories that bank and distribute a wide range of bio specimens including blood-based samples, cell lines, and brain tissue across the country; and the Longitudinal Early-onset AD Study (LEADS), which seeks to characterize early-onset AD in a nation-wide clinical study. In addition, IUSM plays a critical role in other nation-wide programs including the Alzheimer Disease Neuroimaging Initiative (ADNI) Genetics Core, and the National Collegiate Athletic Association -U.S. Department of Defense Concussion Assessment, Research and Education (CARE) Consortium, the largest concussion study in history.
Indiana University is an Equal Opportunity, Affirmative Action employer committed to building a building a diverse learning environment and on supporting the professional development of ethnic minorities, women, and people with disabilities. All qualified applicants will receive consideration for employment without regard to age, color, disability, ethnicity, sex, gender identity, gender expression, genetic information, marital status, national origin, race, religion, sexual orientation, or veteran status.
MD, PhD, or equivalent
History of funding in genomics-based Alzheimer’s research
Department Contact for Questions:
Senem Guler firstname.lastname@example.org
OAA #: IUSM004532016
Internal Number: 6706
About Indiana University
Founded in 1820, Indiana University is the state’s public university system, comprised of two core campuses—IU-Bloomington and IUPUI—and six regional campuses located throughout the state. Combined, the total student population is more than 114,000 undergraduate, graduate and professional school students. IU is one of the largest employers in the state, with over 20,000 faculty and staff. Indiana University is an equal employment and affirmative action employer and a provider of ADA services. Diversity and inclusion remains a core commitment to IU’s mission to cultivate an educational environment that supports equal access, participation and representation on all of its campuses and that provides educational and career opportunities for all.